Topic
Gsk
Recent coverage of Gsk from across the web.
-
Nuvalent shares surge 39% after UK's GSK agrees to buy the drugmaker for $10.6 billion -
STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show -
STAT+: GSK says goodbye to leucovorin (again)
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow